Medical was Ufp Technologies’s largest revenue line in fiscal 2025, bringing in $555.32M of $602.80M (92%).
| Concentration Risk Benchmark | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medical | $286.18M | $346.36M | $450.77M | $555.32M | ||||||||
| Non-Medical | — | $53.72M | $53.65M | $47.47M | ||||||||
| Automotive | $17.49M | — | — | — | ||||||||
| Consumer | — | — | — | — | ||||||||
| Industrial | $34.80M | — | — | — | ||||||||
| Aerospace Defense | $15.33M | — | — | — | ||||||||
| Aerospace &Amp; Defense | — | — | — | — | ||||||||
| Electronics | — | — | — | — | ||||||||
| Total | $353.79M | $400.07M | $504.42M | $602.80M |
Ufp Technologies brought in $602.80M from its two revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 19.5% from $504.42M in fiscal 2024. Medical was the largest at $555.32M (92.1%), ahead of Non-Medical at $47.47M (7.9%).
Compared with fiscal 2024, Medical grew 23.2% to $555.32M, while Non-Medical fell 11.5% to $47.47M.
Ufp Technologies began breaking out Non-Medical in fiscal 2023, when it brought in $53.72M. Ufp Technologies stopped reporting Industrial ($34.80M in fiscal 2022), Automotive ($17.49M in fiscal 2022) and Aerospace Defense ($15.33M in fiscal 2022) as separate revenue lines.
Products was Ufp Technologies’s largest product and service line in fiscal 2025, bringing in $591.36M of $602.80M (98%).
| Product and Service | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Products | — | $391.46M | $491.38M | $591.36M | ||||||
| Product | $342.74M | — | — | — | ||||||
| Tooling & Machinery | $6.31M | $3.47M | $8.32M | $4.50M | ||||||
| Engineering Services | — | $5.14M | $4.72M | $6.94M | ||||||
| Engineering & Development | $4.74M | — | — | — | ||||||
| Total | $353.79M | $400.07M | $504.42M | $602.80M |
Ufp Technologies brought in $602.80M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 19.5% from $504.42M in fiscal 2024. Products was the largest at $591.36M (98.1%), ahead of Engineering Services at $6.94M (1.2%) and Tooling & Machinery at $4.50M (0.7%).
Ufp Technologies began breaking out Products in fiscal 2023 and Engineering Services in fiscal 2023. Ufp Technologies stopped reporting Product ($342.74M in fiscal 2022) and Engineering & Development ($4.74M in fiscal 2022) as separate lines.
Ufp Technologies (UFPT) reports its revenue by concentration risk benchmark and by product and service. In fiscal 2025, Medical was its largest revenue line, bringing in $555.32M (92.1% of the total), followed by Non-Medical at $47.47M (7.9%).
Medical was Ufp Technologies' largest revenue line in fiscal 2025, bringing in $555.32M, or 92.1% of the $602.80M total across its two revenue lines.
Products was Ufp Technologies' largest product and service line in fiscal 2025, bringing in $591.36M, or 98.1% of the $602.80M total across its three product and service lines.
Medical grew faster than Non-Medical in fiscal 2025, up 23.2% from $450.77M to $555.32M. Non-Medical fell 11.5% to $47.47M.
Every figure comes from Ufp Technologies' annual financial filings, as reported. Each line keeps the name Ufp Technologies gives it, and years follow its fiscal calendar.
Ufp Technologies' revenue by concentration risk benchmark goes back to fiscal 2014, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.